Sunshine Biopharma
SBFM
6 hedge funds and large institutions have $61.8K invested in Sunshine Biopharma in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
0.18% less ownership
Funds ownership: 0.29% → 0.1% (-0.18%)
45% less capital invested
Capital invested by funds: $111K → $61.8K (-$49.5K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$32.3K |
| 2 |
Morgan Stanley
New York
|
+$21.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$98.1K |
| 2 |
NA
Nordwand Advisors
Radnor,
Pennsylvania
|
-$1.59K |
| 3 |
JIP
Jaffetilchin Investment Partners
Tampa,
Florida
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
1
Connective Capital Management
Palo Alto,
California
| $34K | +$32.3K | +1,135 | New |
|
|
2
Morgan Stanley
New York
| $22.9K | +$21.8K | +764 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $2.6K | +$2.48K | +87 | New |
|
|
SS
4
SBI Securities
Tokyo,
Japan
| $2.13K | +$2.02K | +71 | New |
|
5
National Bank of Canada
Montreal,
Quebec, Canada
| $21 | – | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| $15 | -$98.1K | -3,447 | -100% |
|
7
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $12 | – | – | – |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $6 | – | – | – |
|
|
FFA
9
Farther Finance Advisors
San Francisco,
California
| $3 | – | – | – |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3 | – | – | – |
|
|
RA
11
Rise Advisors
Rochester,
New York
| $3 | – | – | – |
|
|
TWC
12
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $3 | – | – | – |
|
|
NA
13
Nordwand Advisors
Radnor,
Pennsylvania
| – | -$1.59K | -50 | Closed |
|
|
JIP
14
Jaffetilchin Investment Partners
Tampa,
Florida
| – | -$3 | – | – |
|
SBFM Hedge Fund Activity: Q4 2024 in Review
6 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q4 2024, worth a combined $61.8K — down 45% from $111K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SBFM positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Connective Capital Management, opening a new position worth an estimated $32.3K. The largest seller was Bank of America, cutting an estimated $98.1K.
- 6 institutional investors held Sunshine Biopharma (SBFM) as of Q4 2024, up from 3 in Q3 2024.
- Funds reported $61.8K of Sunshine Biopharma stock for Q4 2024, down 45% quarter-over-quarter.
- 4 funds opened new Sunshine Biopharma positions in Q4 2024 and 1 closed out, a net change of +3 holders.
- The largest Sunshine Biopharma buyer in Q4 2024 was Connective Capital Management, an estimated $32.3K added.
- The largest Sunshine Biopharma seller in Q4 2024 was Bank of America, an estimated $98.1K sold.
Based on aggregated 13F filings for Q4 2024.